SCHEMBL7647451

SCHEMBL7647451

CC(=O)NNS(=O)(=O)c1cc2cc(P(=O)(O)O)c(=O)[nH]c2cc1Cl

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCAT1 P54687 5/20 0.38
GRIN2D O15399 2/20 0.36
GRIN3B O60391 2/20 0.36
GRIA1 P42261 2/20 0.36
GRIA2 P42262 2/20 0.36
GRIA3 P42263 2/20 0.36
GRIA4 P48058 2/20 0.36
GRIN1 Q05586 2/20 0.36
GRIN2A Q12879 2/20 0.36
GRIN2B Q13224 2/20 0.36
GRIN2C Q14957 2/20 0.36
GRIN3A Q8TCU5 2/20 0.36
GRIK1 P39086 1/20 0.33
GRIK2 Q13002 1/20 0.33
GRIK3 Q13003 1/20 0.33
GRIK4 Q16099 1/20 0.33
GRIK5 Q16478 1/20 0.33
THRB P10828 1/20 0.32
MGAM O43451 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7654302 0.86 BCAT1 (0.34) BCAT1GRIN2DGRIN3BGRIA1GRIA2
SCHEMBL6940270 0.85 KAT6A (0.44) BCAT1GRIN2DGRIN3BGRIA1GRIA2
SCHEMBL6939746 0.85 GRIN2D (0.37) GRIN2DGRIN3BGRIA1GRIA2GRIA3
SCHEMBL7648730 0.83 GRIN2D (0.35) BCAT1GRIN2DGRIN3BGRIA1GRIA2
SCHEMBL7648786 0.82 GRIN1 (0.35) GRIN2DGRIN3BGRIA1GRIA2GRIA3
SCHEMBL7652701 0.82 KDM4E (0.37) GRIN2DGRIN3BGRIA1GRIA2GRIA3
SCHEMBL7652655 0.82 GSTO1 (0.37) GRIN2DGRIN3BGRIA1GRIA2GRIA3
SCHEMBL6939707 0.80 POLB (0.36) GRIN2DGRIN3BGRIA1GRIA2GRIA3
SCHEMBL7649274 0.79 BRD4 (0.38) GRIN2DGRIN3BGRIA1GRIA2GRIA3
SCHEMBL2844839 0.78 CA12 (0.40) GRIN2DGRIN3BGRIA1GRIA2GRIA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6486143-B2 NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS LES LABORATOIRES SERVIER (FR) 2002-11-26 US disclosed
US-20010031746-A1 6-amino- or 6-hydrazino-sulphonyl-3-quinolynyl-phosphonic acid compounds LES LABORATOIRES SERVIER (FR) 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031746-A1 6-amino- or 6-hydrazino-sulphonyl-3-quinolynyl-phosphonic acid compounds CA6, P2RY6, FPR3 BCAT1 424/4885GRIN2D 1500/4885GRIN3B 919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.